Biomerica, Inc.
BMRA · NASDAQ
8/31/2025 | 5/31/2025 | 2/28/2025 | 11/30/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 84.2% | -33.1% | -31.6% | – |
| Gross Profit | $0 | -$0 | $0 | $0 |
| % Margin | 30.7% | -32.6% | 1.7% | 26.7% |
| EBITDA | $0 | -$0 | -$0 | -$0 |
| % Margin | 7.8% | -194.9% | -99.3% | -60.7% |
| Net Income | $0 | -$0 | -$0 | -$0 |
| % Margin | 0.1% | -206.1% | -103.9% | -58.1% |
| EPS Diluted | 0.003 | -0.16 | -0.068 | -0.056 |
| % Growth | 101.9% | -135.6% | -22.3% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |